Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1044967]Researchers: Dr Marcel Batten (Principal investigator) , A/Pr Alexander Swarbrick , A/Pr Daniel Christ
Brief description Our data in mice suggest that immune cell signalling protein, interleukin (IL)-27, enhances anti-tumour immune responses and slows growth of mammary tumours and carcinogen induced sarcomas. This project aims to test how IL-27 promotes protective anti-tumour immune responses and to develop a modified IL-27 protein that will be tested as a cancer therapeutic in mice. This will be the first study to examine IL-27 function using physiological tumour models and may provide proof of concept for a new therapeutic strategy for some human cancers.
Funding Amount $AUD 473,960.63
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1044967
- PURL : https://purl.org/au-research/grants/nhmrc/1044967
